Status: Recruiting
HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
This is a Phase 1, open-label, multi-center, competitive enrollment, and dose-escalation study of HCW9302 in subjects with Alopecia Areata (AA)
Participants needed: 30
Trial details
Phase: Phase 1Age: 18-70Biological sex: AllType: InterventionalSponsor: HCW BiologicsUpdated: Oct 20, 2025Locations: 2
Eligibility criteria
Adult women who are 18 to 70 years of age, or adult males who are 18 to 60 years... [+11]
Men and women (of reproductive potential) unwilling to use birth control and wom... [+22]